🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
OptiNose, Inc.
Market Cap: Low
Employees: Low
XHANCE
Opti Nose, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for ear, nose, throat, and allergy specialists in the U.S. Their products include XHANCE for chronic rhinosinusitis with nasal polyps, and Onzetra Xsail, with ongoing developments like OPN-019.
Symbol: OPTN
Recent Price: $0.41
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Ramy A. Mahmoud M.D., M.P.H.
Sector: Healthcare
Employees: 132
Address: 1020 Stony Hill Road, Yardley, PA 19067
Phone: 267 364 3500
Leadership
- Ramy A. Mahmoud, MD, MPH, CEO
- Paul Spence, Chief Commercial Officer
- Terry Kohler, Chief Financial Officer
- Mike Marino, Chief Legal Officer
- Anthony Krick, Chief Accounting Officer
- John Messina, PharmD, Senior Vice President, Clinical Development and Medical Affairs
- Michael C. Berkey, Vice President, Technical Operations
- Karen E. Brophy, Chief Human Resources Officer
- Ramona Lloyd, PhD, RAC, Senior Vice President, Regulatory & Quality
- Jonathan Neely, Vice President, Investor Relations, and Business Development
- R. John Fletcher, Chairman
- Wilhelmus Groenhuysen, Chief Operating Officer
- Sandra L. Helton, Director
- Catherine E. Owen, Director
- Tomas J. Heyman, Director
- Dr. Eric Bednarski, Director
- Dr. Kyle Dempsey, Director
Last updated: 2024-12-31